Fig. 3From: Clinical features and treatment outcomes of pediatric Langerhans cell histiocytosis with macrophage activation syndrome-hemophagocytic lymphohistiocytosisComparison of the recovery time between patients treated with dabrafenib and second-line chemotherapy. A Body temperature; B hemoglobin; C plateletsBack to article page